Our stories

Learn about how small molecules can potentially make a big impact on the future of medicine. They are just one of our tools that are being investigated to unlock new ways to impact serious diseases.

Step inside our Boston Learning Lab and learn about our high school summer internship, one of our signature STEAM education programs.

Listen to Fred Van Goor, Vice President of Cystic Fibrosis Research, talk about our commitment to pursuing new therapeutic advances for all people living with cystic fibrosis and how this commitment drives scientific innovation.

Rebecca Hunt, Vice President of Patient and Community Engagement, highlights Vertex’s uncompromising commitment to patients.

Learn about an essential component in stem cell transplants, known as conditioning regimens. This is just one of the tools in our drug discovery toolbox that could support potential treatments.

Learn how Vertex remains committed to increasing representation in science and medicine through our partnership with the Biomedical Science Careers Program.

Learn about one of our innovative approaches, cell encapsulation. This is just one of the tools in our drug discovery toolbox that has the potential to treat serious diseases.

Learn about one of our innovative approaches, CRISPR/Cas9. This is just one of the tools in our drug discovery toolbox that has the potential to unlock new ways to impact genetic diseases.

Mark Higgins, Senior Director of Clinical Development, highlights Vertex’s patient-first approach to clinical trials and discusses his experience discovering potential treatments for people with cystic fibrosis.

Looking back on 2022, the Vertex Foundation remains grateful and excited for the future. From supporting healthy families to social innovation and STEAM education, we’re proud of the impact Foundation partners continue to make in our communities around the world. 

Cystic fibrosis is a rare, genetic, progressive disease, in which symptoms and organ damage can manifest very early in life. These may not, however, be outwardly visible in all children and while some children can appear well on the outside, what is happening inside their bodies can tell a different story. 

We are lucky to have some of our very own ‘Vertexians’ willing to share their stories about living with or caring for someone with T1D. We invite you to learn from them and help raise awareness for T1D this month.

Derya Balata and Teame Araya are Vertex’s newest Science Leaders Scholars. Learn more about these two outstanding students who have been selected to receive a four-year, full scholarship to pursue a STEM-related course of study at the University of Massachusetts.

This September, join us in recognizing Duchenne Action Month by learning from some of our female scientists working on Duchenne muscular dystrophy (DMD). These scientists are passionate about their research and raising awareness for DMD.

Vertex is proud to share that it has been named — once again — to Seramount’s 100 Best Companies list and the Best Companies for Dads list. Learn more about what sets us apart and meet our Working Parents of the Year honorees, Genzy Davis and Ravin Warnakulasuriya. 

Incredible talent and cross-functional collaboration. All that and more with Vertex’s type 1 diabetes team. Meet a few of the team members who are making a difference.